Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- Santiago Arroyo, M.D., Ph.D., appointed Chief Development Officer
- Jennifer Perry, Pharm.D., promoted to Senior Vice President, Commercial
. | April 3, 2023
Bicycle and Novartis will collaborate on the discovery and development of multiple targeted radioligand therapies in oncology Bicycle will receive a $50 million upfront payment as well as potential
Bicycle Therapeutics Plc (BCYC) Reports Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced